Clinical Trial Update: Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an anti-PD-1 antibody in combination with pegaspargase for nasal type extranodal NK/T-cell lymphoma is in progress, with status not spe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Type Extranodal Nk T-cell Lymphoma

Drugs mentioned

• Anti-PD-1 antibody
• Pegaspargase (pegaspargase)

Snippet

Sponsor: Ruijin Hospital | Conditions: Nasal Type Extranodal NK/T-Cell Lymphoma | Phase 2 | Status: UNKNOWN